Fluorouracil-Uracil and Leucovorin in Treating Elderly Patients With Metastatic Colorectal Cancer

Sponsor
Eastern Cooperative Oncology Group (Other)
Overall Status
Completed
CT.gov ID
NCT00004860
Collaborator
National Cancer Institute (NCI) (NIH)
51

Study Details

Study Description

Brief Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.

PURPOSE: Phase II trial to study the effectiveness of fluorouracil-uracil and leucovorin in treating elderly patients who have metastatic colorectal cancer.

Condition or Disease Intervention/Treatment Phase
Phase 2

Detailed Description

OBJECTIVES: I. Determine the response rate of elderly patients with metastatic colorectal cancer treated with fluorouracil-uracil and leucovorin calcium (Orzel). II. Evaluate the toxicity profile of this regimen in this patient population. III. Compare response rates obtained in this study with those observed in recent phase III studies in younger patients.

OUTLINE: Patients receive oral fluorouracil-uracil and oral leucovorin calcium (Orzel) every 8 hours for 28 days. Courses repeat every 35 days in the absence of unacceptable toxicity or disease progression. Patients are followed every 3 months for 2 years, every 6 months for 3 years, and then annually thereafter.

PROJECTED ACCRUAL: A total of 20-55 patients will be accrued for this study within 1 year.

Study Design

Study Type:
Interventional
Primary Purpose:
Treatment
Official Title:
A Phase II Study of ORZEL (UFT + Leucovorin) in Elderly (at Least 75 Years Old) Patients With Colorectal Cancer
Study Start Date :
Jun 1, 2000
Actual Primary Completion Date :
Oct 1, 2005

Outcome Measures

Primary Outcome Measures

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    75 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No

    DISEASE CHARACTERISTICS: Histologically confirmed metastatic colorectal adenocarcinoma Measurable disease

    PATIENT CHARACTERISTICS: Age: 75 and over Performance status: ECOG 0-2 Life expectancy: Not specified Hematopoietic: Absolute neutrophil count at least 1,500/mm3 Platelet count at least 100,000/mm3 Hepatic: Bilirubin no greater than 1.5 mg/dL AST or ALT no greater than 2.5 times upper limit of normal (ULN) Renal: Creatinine no greater than 1.5 times ULN Other: No serious infection No other serious underlying medical condition that would preclude protocol therapy No known hypersensitivity to fluorouracil-uracil or leucovorin calcium

    PRIOR CONCURRENT THERAPY: Biologic therapy: At least 6 months since prior adjuvant immunotherapy for colorectal cancer No concurrent immunotherapy Chemotherapy: At least 6 months since prior adjuvant chemotherapy for colorectal cancer No other concurrent chemotherapy Endocrine therapy: No concurrent hormonal therapy Radiotherapy: See Disease Characteristics At least 6 months since prior adjuvant radiotherapy for colorectal cancer Prior radiotherapy for locally symptomatic disease allowed Surgery: Prior surgery allowed Other: No prior therapy for metastatic disease No other concurrent investigational drugs No concurrent halogenated antiviral agents (e.g., lodenosine, fialuridine, FMAU, emtricitabine, and sorivudine)

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 CCOP - Scottsdale Oncology Program Scottsdale Arizona United States 85259-5404
    2 Beckman Research Institute, City of Hope Los Angeles California United States 91010
    3 Veterans Affairs Medical Center - Palo Alto Palo Alto California United States 94304
    4 Stanford University Medical Center Stanford California United States 94305-5408
    5 CCOP - Colorado Cancer Research Program, Inc. Denver Colorado United States 80209-5031
    6 CCOP - Christiana Care Health Services Wilmington Delaware United States 19899
    7 Walter Reed Army Medical Center Washington District of Columbia United States 20307-5000
    8 Veterans Affairs Medical Center - Gainsville Gainesville Florida United States 32608-1197
    9 H. Lee Moffitt Cancer Center and Research Institute Tampa Florida United States 33612
    10 Veterans Affairs Medical Center - Tampa (Haley) Tampa Florida United States 33612
    11 CCOP - Evanston Evanston Illinois United States 60201
    12 CCOP - Illinois Oncology Research Association Peoria Illinois United States 61602
    13 CCOP - Carle Cancer Center Urbana Illinois United States 61801
    14 Indiana University Cancer Center Indianapolis Indiana United States 46202-5265
    15 Veterans Affairs Medical Center - Indianapolis (Roudebush) Indianapolis Indiana United States 46202
    16 CCOP - Iowa Oncology Research Association Des Moines Iowa United States 50309-1016
    17 MBCCOP - LSU Health Sciences Center New Orleans Louisiana United States 70112
    18 Johns Hopkins Oncology Center Baltimore Maryland United States 21231
    19 New England Medical Center Hospital Boston Massachusetts United States 02111
    20 Beth Israel Deaconess Medical Center Boston Massachusetts United States 02215
    21 CCOP - Ann Arbor Regional Ann Arbor Michigan United States 48106
    22 Veterans Affairs Medical Center - Minneapolis Minneapolis Minnesota United States 55417
    23 University of Minnesota Cancer Center Minneapolis Minnesota United States 55455
    24 Mayo Clinic Cancer Center Rochester Minnesota United States 55905
    25 Veterans Affairs Medical Center - East Orange East Orange New Jersey United States 07018-1095
    26 CCOP - Northern New Jersey Hackensack New Jersey United States 07601
    27 Fox Chase Cancer Center at Virtua Memorial Hospital Burlington County Mount Holly New Jersey United States 08060
    28 Veterans Affairs Medical Center - Brooklyn Brooklyn New York United States 11209
    29 NYU School of Medicine's Kaplan Comprehensive Cancer Center New York New York United States 10016
    30 University of Rochester Cancer Center Rochester New York United States 14642
    31 CCOP - Merit Care Hospital Fargo North Dakota United States 58122
    32 Veterans Affairs Medical Center - Cleveland Cleveland Ohio United States 44106
    33 CCOP - Columbus Columbus Ohio United States 43206
    34 CCOP - Toledo Community Hospital Oncology Program Toledo Ohio United States 43623-3456
    35 CCOP - Sooner State Tulsa Oklahoma United States 74136
    36 CCOP - Geisinger Clinic and Medical Center Danville Pennsylvania United States 17822-2001
    37 Hahnemann University Hospital Philadelphia Pennsylvania United States 19102-1192
    38 University of Pennsylvania Cancer Center Philadelphia Pennsylvania United States 19104
    39 Kimmel Cancer Center of Thomas Jefferson University - Philadelphia Philadelphia Pennsylvania United States 19107
    40 Fox Chase Cancer Center Philadelphia Pennsylvania United States 19111
    41 University of Pittsburgh Cancer Institute Pittsburgh Pennsylvania United States 15213
    42 Veterans Affairs Medical Center - Pittsburgh Pittsburgh Pennsylvania United States 15240
    43 CCOP - Sioux Community Cancer Consortium Sioux Falls South Dakota United States 57105-1080
    44 Veterans Affairs Medical Center - Nashville Nashville Tennessee United States 37212
    45 Vanderbilt-Ingram Cancer Center Nashville Tennessee United States 37232-6838
    46 Veterans Affairs Medical Center - Madison Madison Wisconsin United States 53705
    47 University of Wisconsin Comprehensive Cancer Center Madison Wisconsin United States 53792
    48 Medical College of Wisconsin Milwaukee Wisconsin United States 53226
    49 Veterans Affairs Medical Center - Milwaukee (Zablocki) Milwaukee Wisconsin United States 53295
    50 MBCCOP - San Juan San Juan Puerto Rico 00927-5800
    51 Veterans Affairs Medical Center - San Juan San Juan Puerto Rico 00927-5800

    Sponsors and Collaborators

    • Eastern Cooperative Oncology Group
    • National Cancer Institute (NCI)

    Investigators

    • Study Chair: Howard S. Hochster, MD, NYU Langone Health

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT00004860
    Other Study ID Numbers:
    • CDR0000067511
    • E-1299
    First Posted:
    Apr 12, 2004
    Last Update Posted:
    Aug 23, 2013
    Last Verified:
    Aug 1, 2013

    Study Results

    No Results Posted as of Aug 23, 2013